HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 83: | Line 83: | ||
| | | | ||
|- | |- | ||
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |Assistant Professor, Pathology | |Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' | || || || || ||FQR|| || | ||
|Juvenile Myelomonocytic Leukemia (JMML) | |||
|<nowiki>Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology</nowiki> | |||
Associate Director | Division of Molecular Pathology, Genetics and Genomics | |||
Duke University Health System Clinical Laboratories | |||
|PENDING importing content and reference formatting | |||
| | | | ||
| | |FQR has emailed SR several times, last 4/20/22 | ||
|- | |- | ||
|Myeloproliferative neoplasm, NOS||Disease|| | |Myeloproliferative neoplasm, NOS||Disease|| || || || || ||FQR|| || | ||
| | |Myeloproliferative Neoplasm (MPN), Unclassifiable | ||
| | |Thomas Lee, MD, PhD, University of California, Los Angeles | ||
| | |Complete | ||
| | | | ||
| | | | ||